Synopsis of recent research by authors named "Qinying Liu"
- Qinying Liu's recent research focuses on the interplay between metabolic processes and cancer therapies, particularly examining the roles of specific genes and cell types in cervical, ovarian, and breast cancers, as well as novel treatment strategies involving engineered immune cells and nanoparticles.
- Key findings indicate that silencing splicing factor PTBP1 induces apoptosis in cervical cancer cells via the PI3K/AKT pathway and autophagy, while targeting metabolic gene signatures offers potential prognostic value for endometrial carcinoma and ovarian cancer.
- Liu's studies also highlight innovative approaches such as the development of GPC3-specific CAR-T cells combined with PD-1 blockade and the engineering of dual-targeted nanoparticles for efficient drug delivery, showcasing advancements in overcoming resistance mechanisms in solid tumors.
